Glaucoma Clinical Trials

Find Glaucoma Clinical Trials Near You

Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The EVOLUTION is a 10-year extension of the ENVOL study. It seeks to compare the evolution of structural and functional connectivity (Hub Disruption Index) and cerebral volume on 3T MRI of the brain in glaucoma patients and matched controls. The study aims to examine the hypothesis that glaucomatous optic neuropathy is not limited solely to the visual pathway, but rather is associated with a broader degeneration of the central nervous system.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• having been previously included and completed the ENVOL study

• Ability and willingness to provide informed consent

• Having a valid health insurance in France

∙ In glaucoma group :

• Glaucomatous optic neuropathy, being able to be graded by the vertical C/D ratio

• Open angle on gonioscopy in a dark-room testing according to Shaffer's classification (grade 3 or grade 4)

• Visual field impairement (at least one of the following) :

‣ 3 adjacent points with at least 5dB loss

⁃ one point with a loss of 10dB

⁃ a difference of at least 10 dB for 2 adjacent points on either side of the horizontal meridian of the nasal visual field

• Mini Mental State Score of at least 28

∙ In control group :

• No personal or family history of glaucoma or ocular hypertension (IOP \> 21 mmHg)

• Open angle on gonioscopy in a dark-room testing according to Shaffer's classification (grade 3 or grade 4)

• Intraocular pressure of ≤ 21 mmHg

• Absence of glaucomatous neuropathy

• Normal visual field

Locations
Other Locations
France
CHU Bordeaux
RECRUITING
Bordeaux
Contact Information
Primary
Cedrick Schweitzer, MD, PhD
cedric.schweitzer@chu-bordeaux.fr
+335 56 79 55 30
Time Frame
Start Date: 2026-08-28
Estimated Completion Date: 2027-05
Participants
Target number of participants: 100
Treatments
Experimental: Patient with glaucoma
Patient with glaucoma
Active_comparator: Patient without glaucoma
Patient without glaucoma
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov